SCHEMBL29559982

SCHEMBL29559982

O=S(=O)(Cl)c1cn(S(=O)(=O)c2ccccc2)c2cc3c(cc12)OCO3

nearest known ligand 0.45

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 15/20 0.45
▸ CYP3A4 P08684 2/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ HTR2B P41595 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TP53 P04637 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20354780 1.00 HTR6 (0.45) HTR6CYP3A4HTR2AHTR2CHTR2B
SCHEMBL2879938 0.80 KDM4E (0.51) HTR6CYP3A4HTR2AHTR2CHTR2B
SCHEMBL12748777 0.80 AKR1C3 (0.53) HTR6CYP3A4HTR2AHTR2CHTR2B
SCHEMBL29651295 0.77 HTR6 (0.60) HTR6CYP3A4CYP2D6
SCHEMBL22864566 0.77 HTR6 (0.60) HTR6CYP3A4CYP2D6
SCHEMBL29365118 0.76 HTR6 (0.55) HTR6CYP3A4HTR2AHTR2CHTR2B
SCHEMBL20354867 0.76 HTR6 (0.55) HTR6CYP3A4HTR2AHTR2CHTR2B
SCHEMBL29365123 0.76 HTR6 (0.55) HTR6CYP3A4HTR2AHTR2CHTR2B
SCHEMBL2885241 0.75 MEN1 (0.65) HTR6RXFP1MAPTTP53HPGD
SCHEMBL21596675 0.75 L3MBTL1 (0.47) HTR6CYP3A4HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2024-08-27 — — US disclosed
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2023-11-21 — — US disclosed
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2023-11-02 — — US disclosed
CN-116283712-A (aza) indole-, benzothiophene-and benzofuran-3-sulfonamides 优时比制药有限公司 2023-06-23 — — CN disclosed
CN-116036078-A (aza) indole-, benzothiophene-and benzofuran-3-sulfonamides 优时比制药有限公司 2023-05-02 — — CN disclosed
CN-110121499-B (aza) indole-, benzothiophene-and benzofuran-3-sulfonamides 优时比制药有限公司 2022-12-20 — — CN disclosed
US-11345662-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides UCB PHARMA GMBH (DE) 2022-05-31 — — US disclosed
US-20220127227-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides UCB PHARMA GMBH (DE) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127227-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides GPR17, GPR18, GPR27 HTR6 638/4885CYP3A4 2597/4885HTR2A 649/4885
US-11345662-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 HTR6 638/4885CYP3A4 2597/4885HTR2A 649/4885
US-11820746-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 HTR6 638/4885CYP3A4 2597/4885HTR2A 649/4885
US-20230348384-A1 Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides GPR17, GPR18, GPR27 HTR6 638/4885CYP3A4 2597/4885HTR2A 649/4885
US-12071404-B2 Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides GPR17, GPR18, GPR27 HTR6 638/4885CYP3A4 2597/4885HTR2A 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback